DrugPatentWatch Database Preview
PHOTREXA Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Photrexa, and what generic alternatives are available?
The generic ingredient in PHOTREXA is riboflavin 5'-phosphate sodium. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the riboflavin 5'-phosphate sodium profile page.
Summary for PHOTREXA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 31 |
| Clinical Trials: | 1 |
| Patent Applications: | 2,506 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PHOTREXA at DailyMed |
Medical Subject Heading (MeSH) Categories for PHOTREXA
Synonyms for PHOTREXA
| 130-40-5 |
| 1336438-57-3 |
| 146-17-8 (Parent) |
| 214464-97-8 |
| 22251-85-0 |
| 5'-(Dihydrogen Phosphate)riboflavin Sodium |
| 7,8-Dimethyl-10-ribitylisoalloxazine Phosphate Sodium |
| 957E53WV42 |
| AB1009290 |
| AC1Q1VB9 |
| API0006955 |
| C17H20N4O9P.Na |
| CHEBI:32098 |
| CHEMBL1201795 |
| CS-4449 |
| D01622 |
| E106 |
| EINECS 204-988-6 |
| EINECS 244-868-0 |
| flavin mononucleotide |
| Flavin Mononucleotide Sodium Salt |
| FMN-Na |
| FT-0658440 |
| HY-B0964 |
| hyryl |
| Infuvite (TN) |
| Lactoflavin Phosphate Sodium Salt |
| MFCD00065362 |
| MFCD00150992 |
| MolPort-003-939-021 |
| OHSHFZJLPYLRIP-BMZHGHOISA-M |
| Photrexa Viscous In Dextran 20% |
| R0023 |
| Riboflavin (phosphate sodium) |
| Riboflavin 5 inverted exclamation marka-monophosphate sodium salt |
| Riboflavin 5'-(dihydrogen phosphate), monosodium salt |
| Riboflavin 5'-(dihydrogen phosphate), sodium salt |
| Riboflavin 5'-(dihydrogen phosphate), sodium salt (1:1) |
| Riboflavin 5'-(sodium hydrogen phosphate) |
| Riboflavin 5'-monophosphate sodium salt |
| Riboflavin 5'-phosphate sodium |
| Riboflavin 5'-phosphate sodium anhydrous |
| Riboflavin 5'-phosphate sodium salt |
| Riboflavin Mononucleotide Sodium |
| Riboflavin monophosphate monosodium salt |
| RIBOFLAVIN PHOSPHATE SODIUM |
| Riboflavin Phosphate Sodium Salt |
| riboflavin sodium phosphate |
| Riboflavin sodium phosphate (JP17) |
| Riboflavin sodium phosphate; Riboflavini natrii phosphas |
| Riboflavin-5-phosphate sodium |
| Riboflavin-5'-phosphate monosodium salt dihydrate |
| Riboflavin-5'-phosphate sodium |
| Riboflavina 5 fosfato de sodio |
| Riboflavine 5-Phosphate Sodium |
| Riboflavine Monophosphate Sodium |
| Riboflavine Phosphate Sodium |
| Riboflavine-5'-phosphate sodium |
| Riboflavini natrii phosphas |
| SCHEMBL26122 |
| Sodium riboflavin 5'-phosphate |
| sodium;[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate |
| UNII-957E53WV42 |
| Vitamin B2 Phosphate Sodium |
| Vitamin B2 Phosphate Sodium Salt |
| W-108348 |
| X2938 |
US Patents and Regulatory Information for PHOTREXA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avedro Inc | PHOTREXA | riboflavin 5'-phosphate sodium | SOLUTION/DROPS;OPHTHALMIC | 203324-001 | Apr 15, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Avedro Inc | PHOTREXA VISCOUS IN DEXTRAN 20% | riboflavin 5'-phosphate sodium | SOLUTION/DROPS;OPHTHALMIC | 203324-002 | Apr 15, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Avedro Inc | PHOTREXA | riboflavin 5'-phosphate sodium | SOLUTION/DROPS;OPHTHALMIC | 203324-001 | Apr 15, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Avedro Inc | PHOTREXA | riboflavin 5'-phosphate sodium | SOLUTION/DROPS;OPHTHALMIC | 203324-001 | Apr 15, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
